"GLP-1 medications can be an effective tool for weight management by promoting slowed digestion, increased satiety, and appetite regulation," says Daniel Chavez, RD
M., Martinou, E
In practice, many obesity specialists have found themselves deviating from the label slowing down titration, adding intermediate doses, maintaining lower doses longer, or skipping weeks to help patients stay on therapy
Disclosures: Xiaobin Zao: Nothing to Disclose, Xu Cao: Nothing to Disclose, Yijun Liang: Nothing to Disclose, Ruijia Liu: Nothing to Disclose, Wenying Qi: Nothing to Disclose, Yue Chen: Nothing to Disclose, Yong'An Ye: Nothing to Disclose 1917 IMPACT OF COVID-19 ON PRIMARY LIVER CANCER-RELATED MORTALITY IN THE UNITED STATES Young Eun Chon 1 Mohammad Saeid Rezaee-Zavareh 2 Yee Hui Yeo 3 Hyunseok Kim 3 Alexander Kuo 3 Walid Ayoub 3 Hirsh Trivedi 3 Yun Wang 3 Aarshi Vipani 3 Cristina Ferrone 3 Kambiz Kosari 3 Nicholas Nissen 3 Nicole Rich 4 Neehar Parikh 5 Amit Singal 4 Ju Dong Yang 3 , 1 CHA University, 2 Middle East Liver Diseases Center, 3 Cedars-Sinai Medical Center, 4 University of Texas Southwestern Medical Center, 5 University of Michigan Medical Center Background: Disruptions in health care during the COVID-19 pandemic may have affected the mortality trends of primary liver cancer
Disclosures: Phuc Le: Nothing to Disclose, William Herman: Merck Sharp & Dohme: Advisor, Rivus Pharmaceuticals: Advisor, Srinivasan Dasarathy: Nothing to Disclose, Wen Ye: Nothing to Disclose, Victoria Criswell: Nothing to Disclose, Nicole Welch: Nothing to Disclose, Michael Rothberg: Moderna: Stock - publicly traded company 1763 CLINICAL OUTCOMES OF UTILIZING AN INTERACTIVE CARE PLAN (ICP) IN PATIENTS WITH CIRRHOSIS Kathryn Schmidt 1 Jessica Grimm 1 Devin Copley 1 Daniel Penrice 1 Barbara Copeland 1 William Harmsen 1 Rachel Gullerud 1 Winnie Fan 1 Jordan Coffey 1 Julianne Lunde 1 Sarah Harper 1 Hugo Vargas 2 Blanca Lizaola-Mayo 2 Douglas Simonetto 1 , 1 Mayo Clinic Rochester, 2 Mayo Clinic Arizona Background: Patients with cirrhosis face an increased risk of disease-related symptoms and complications, leading to reduced quality of life
